How Will Spending Growth Impact the Specialty Pharmacy Patient Experience?

Video

Daniel P. Kus, BS Pharm, RPh, discusses how the growth of drug prices could impact the specialty pharmacy patient experience.

Daniel P. Kus, BS Pharm, RPh, discusses how the growth of drug prices could impact the specialty pharmacy patient experience.

Related Videos
Medical professional researching on a laptop while taking notes
Credit: Adobe Stock - Tierney
https://www.youtube.com/watch?v=Q-WCvWaAcC8
Yaruniv-Studio - stock.adobe.com
Technician- © pharmacytimes
Related Content

Tenth Circuit Decision Invalidates Oklahoma PBM Rules

September 20th 2023

Pharmacy Focus: Psychedelic Pharmacy - Ibogaine Offers Unique Benefits

September 8th 2023

Patients With Cancer Using Nonmedical Stimulants Can Continue Using Opioids, Regardless of Prognosis

September 13th 2023

Public Health Matters - Discussing Charitable Pharmacies

July 6th 2023

Phase 3 Trial Shows Combined Nivolumab, Ipilimumab Treatment Improved OS in Patients With mNSCLC

September 12th 2023

Osimertinib, Chemotherapy Show Survival Benefit for Patients With Advanced, Mutated Lung Cancer

September 11th 2023

Tenth Circuit Decision Invalidates Oklahoma PBM Rules

September 20th 2023

Pharmacy Focus: Psychedelic Pharmacy - Ibogaine Offers Unique Benefits

September 8th 2023

Patients With Cancer Using Nonmedical Stimulants Can Continue Using Opioids, Regardless of Prognosis

September 13th 2023

Public Health Matters - Discussing Charitable Pharmacies

July 6th 2023

Phase 3 Trial Shows Combined Nivolumab, Ipilimumab Treatment Improved OS in Patients With mNSCLC

September 12th 2023

Osimertinib, Chemotherapy Show Survival Benefit for Patients With Advanced, Mutated Lung Cancer

September 11th 2023

Tenth Circuit Decision Invalidates Oklahoma PBM Rules

September 20th 2023

Pharmacy Focus: Psychedelic Pharmacy - Ibogaine Offers Unique Benefits

September 8th 2023

Patients With Cancer Using Nonmedical Stimulants Can Continue Using Opioids, Regardless of Prognosis

September 13th 2023

Public Health Matters - Discussing Charitable Pharmacies

July 6th 2023

Phase 3 Trial Shows Combined Nivolumab, Ipilimumab Treatment Improved OS in Patients With mNSCLC

September 12th 2023

Osimertinib, Chemotherapy Show Survival Benefit for Patients With Advanced, Mutated Lung Cancer

September 11th 2023
© 2023 MJH Life Sciences

All rights reserved.